Learn more

VISTAGEN THERAPEUTICS INC

Overview
  • Total Patents
    57
  • GoodIP Patent Rank
    27,247
  • Filing trend
    ⇧ 66.0%
About

VISTAGEN THERAPEUTICS INC has a total of 57 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NANJING NORATE PHARMACEUTICAL TECH CO LTD, UNITED THERAPEUTICS CORP and BIOREX KFT.

Patent filings per year

Chart showing VISTAGEN THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Snodgrass H Ralph 25
#2 Hicklin Jack S 21
#3 Cato Allen E 20
#4 Abele Stefan 8
#5 Laue Klaus 8
#6 Breitenmoser Roland A 7
#7 H Ralph Snodgrass 6
#8 Jack S Hicklin 6
#9 Allen E Cato 5
#10 Snodgrass Ralph H 5

Latest patents

Publication Filing date Title
WO2020210473A1 Genetic variants associated with response to treatment of neurological disorders
WO2019157426A1 Synthesis of 4-chlorokynurenines and intermediates
CN107949379A The therapeutical uses of 4 chloro kynurenins of L
CN105164100A Methods for the synthesis of chiral kynurenine compounds
CN105164096A Synthesis of chiral kynurenine compounds and intermediates
MX2015009277A Dosage forms and therapeutic uses l-4-chlorokynurenine.
WO2011119942A1 Induction of ips cells using transient episomal vectors
EP2297298A2 Pancreatic endocrine progenitor cells derived from pluripotent stem cells